Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes Contracts + Grants March 13, 2019 …
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing Contracts + Grants January 22, 2019 …
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness Featured News January 22, 2019 …
BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures Contracts + Grants January 14, 2019 …
Ridgeback Biotherapeutics Licenses mAb114 Ebola Treatment from NIAID Industry News December 13, 2018 …
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine Contracts + Grants November 15, 2018 …
Two Vaccines Against H7N9 Influenza Viruses Show Safety and Immunogenicity in Ferrets Featured News November 11, 2018 …
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated Featured News November 8, 2018 …
Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’ Antimicrobial Resistance November 6, 2018 …
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox Medical Countermeasures October 4, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
